FIGS

FIGS, Inc. 10-Q Summary: Q2 2024

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2024. FIGS, Inc. is a direct-to-consumer healthcare apparel and lifestyle brand, primarily selling scrubwear and non-scrubwear to healthcare professionals. The company operates a digital platform and physical "Community Hub" retail stores. As of June 30, 2024, the company reported approximately 2.6 million active customers.

Key Financial Metrics

Liquidity & Debt: The company holds $131.8 million in cash and cash equivalents and $136.7 million in short-term investments. It maintains a $100 million revolving credit facility with Bank of America, with $95.1 million available and no outstanding borrowings as of June 30, 2024.

Material Changes vs. Prior Period

• Revenue Growth Slowdown: Net revenues increased 4.4% in Q2 and 2.0% YTD compared to the prior year, driven by increased orders from existing customers but offset by a decrease in Average Order Value (AOV).
• Margin Compression: Gross margin decreased 210 basis points in Q2 (to 67.4%) and 220 basis points YTD (to 68.1%). Management attributed this primarily to a product mix shift favoring limited-edition items and rising freight costs.
• Profitability Decline: Net income dropped significantly, down 76% in Q2 and 61% YTD. This was driven by higher operating expenses and lower gross margins.
• Operating Expenses: Total operating expenses increased 7.0% in Q2. Selling expenses rose due to fulfillment transition costs, and marketing expenses increased due to the 2024 Olympics campaign.
• Interest Income: Other income increased 86.6% in Q2 due to higher interest rates on cash and short-term investment balances.

Guidance, Outlook, and Risks

Management Commentary & Initiatives:

• Fulfillment Transition: The company is transitioning operations from City of Industry, CA, to a new facility in Goodyear, AZ, expected to complete by Q3 2024. This incurred $7.0 million in capital expenditures in Q2, with an additional $2.0–$3.0 million expected for the remainder of the year.
• Share Repurchase: On August 8, 2024, the Board authorized a $50.0 million share repurchase program with no expiration date. No shares have been repurchased to date.
• Supplier Transition: FIGS intends to transition away from a key supplier in Jordan following allegations of labor conditions not meeting company standards. This transition is expected to be gradual but may incur additional costs.

Risks and Contingencies:

• Supply Chain Disruptions: Ongoing conflict in the Middle East has caused shipping delays and increased freight rates, impacting raw material delivery and finished goods.
• Legal Proceedings: A putative securities class action and related derivative suits are pending. The company intends to vigorously defend these claims; no accrual has been recorded as potential loss is not estimable.
• Macroeconomic Factors: Risks include inflation, high interest rates, and potential recessionary pressures affecting consumer spending and the healthcare workforce.

Investor Verification Checklist

• Supplier Transition Impact: Verify the timeline and cost implications of moving away from the Jordanian supplier and the success of diversifying the manufacturing base.
• Fulfillment Transition Costs: Monitor the completion of the Arizona facility move and whether the projected efficiency gains offset the current capital expenditure and transition costs.
• Gross Margin Trajectory: Assess whether the margin compression is temporary (due to mix/freight) or structural, and if pricing power can be maintained.
• Customer Retention: Review trends in active customer growth and repeat purchase frequency, as revenue growth is currently driven by existing customers rather than new acquisition.
• Legal Exposure: Track the status of the securities class action litigation for potential settlement costs or reputational damage.